Novartis AG (NOVN) Receives a Hold From Berenberg Bank
Novartis AG (NOVN) Receives a Hold From Goldman Sachs
Research Alert: CFRA Keeps Hold Opinion On Adss Of Novartis Ag
Deutsche Bank Sticks to Its Buy Rating for Novartis AG (NOVN)
Bernstein Sticks to Their Buy Rating for Novartis AG (NOVN)
Novartis AG (NOVN) Gets a Hold From UBS
Cautious Hold Rating for Novartis AG Amid Mixed Performance and Future Uncertainties
HSBC Initiates Novartis AG(NVS.US) With Sell Rating, Announces Target Price $88
Research Alert: Novartis Raises Guidance After Q1 2025 Beat
Kepler Capital Keeps Their Buy Rating on Novartis AG (NOVN)
Novartis AG: Stable Outlook With Mixed Product Performance and Favorable Forex Impact Justifies Hold Rating
AlphaValue/Baader Europe Lifts Novartis Price Target on Upbeat Earnings Outlook
BNP Paribas Initiates Novartis at Outperform Rating, $116 Price Target
Novartis AG (NOVN) Receives a Hold From J.P. Morgan
UBS Reaffirms Their Hold Rating on Novartis AG (NOVN)
Bernstein Reaffirms Their Buy Rating on Novartis AG (NOVN)
Barclays Reaffirms Their Sell Rating on Novartis AG (NOVN)
Kepler Capital Keeps Their Buy Rating on Novartis AG (NOVN)
Berenberg Bank Keeps Their Hold Rating on Novartis AG (NOVN)
Novartis AG (NOVN) Gets a Buy From Kepler Capital